Evelo Biosciences, Inc. (NASDAQ:EVLO – Get Free Report) was the recipient of unusually large options trading on Wednesday. Stock investors bought 1,885 put options on the stock. This is an increase of 1,101% compared to the typical volume of 157 put options.
Evelo Biosciences Stock Performance
The firm has a market cap of $9,000.00, a price-to-earnings ratio of 0.00 and a beta of 0.59. Evelo Biosciences has a 52 week low of $0.00 and a 52 week high of $0.00.
About Evelo Biosciences
Evelo Biosciences is a clinical-stage biotechnology company developing orally delivered immunomodulatory therapies that leverage the gut-body network. The company’s proprietary platform is designed to mimic signals normally generated by gut commensal bacteria to regulate immune function throughout the body. Evelo’s approach focuses on non-live, inactivated microbial derivatives, aiming to offer a new class of biologics that can be administered by mouth and engage mucosal immune pathways to treat a range of diseases.
The company’s pipeline spans inflammatory, autoimmune and oncology indications.
Read More
Receive News & Ratings for Evelo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evelo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
